Literature DB >> 35747225

Should we still have the COURAGE to perform elective PCI in stable myocardial ISCHEMIA?

Telal Mudawi1, Darar Al-Khdair2, Muath Al-Anbaei3, Asmaa Ali4, Ahmed Amin4, Dalia Besada4, Waleed Alenezi4.   

Abstract

Entities:  

Keywords:  BARI 2 trial; COURAGE trial; ISCHEMIA trial; percutaneous coronary intervention (PCI); stable coronary disease

Year:  2020        PMID： 35747225      PMCID： PMC9205255          DOI： 10.5837/bjc.2020.033

Source DB:  PubMed          Journal:  Br J Cardiol        ISSN： 0969-6113


× No keyword cloud information.
  24 in total

1.  Impact of delay to angioplasty in patients with acute coronary syndromes undergoing invasive management: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial.

Authors:  Paul Sorajja; Bernard J Gersh; David A Cox; Michael G McLaughlin; Peter Zimetbaum; Costantino Costantini; Thomas Stuckey; James E Tcheng; Roxana Mehran; Alexandra J Lansky; Cindy L Grines; Gregg W Stone
Journal:  J Am Coll Cardiol       Date:  2010-04-06       Impact factor: 24.094

2.  Simple risk stratification at admission to identify patients with reduced mortality from primary angioplasty.

Authors:  Jens Jakob Thune; Dan Eik Hoefsten; Matias Greve Lindholm; Leif Spange Mortensen; Henning Rud Andersen; Torsten Toftegaard Nielsen; Lars Kober; Henning Kelbaek
Journal:  Circulation       Date:  2005-09-27       Impact factor: 29.690

3.  Myocardial salvage after coronary stenting plus abciximab versus fibrinolysis plus abciximab in patients with acute myocardial infarction: a randomised trial.

Authors:  Adnan Kastrati; Julinda Mehilli; Josef Dirschinger; Ullrich Schricke; Jodi Neverve; Jürgen Pache; Stefan Martinoff; Franz Josef Neumann; Stephan Nekolla; Rudolf Blasini; Melchior Seyfarth; Markus Schwaiger; Albert Schömig
Journal:  Lancet       Date:  2002-03-16       Impact factor: 79.321

4.  Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease. Atorvastatin versus Revascularization Treatment Investigators.

Authors:  B Pitt; D Waters; W V Brown; A J van Boven; L Schwartz; L M Title; D Eisenberg; L Shurzinske; L S McCormick
Journal:  N Engl J Med       Date:  1999-07-08       Impact factor: 91.245

5.  A randomized trial of transfer for primary angioplasty versus on-site thrombolysis in patients with high-risk myocardial infarction: the Air Primary Angioplasty in Myocardial Infarction study.

Authors:  Cindy L Grines; Donald R Westerhausen; Lorelei L Grines; J Timothy Hanlon; Timothy L Logemann; Matti Niemela; W Douglas Weaver; Marianne Graham; Judith Boura; William W O'Neill; Carlos Balestrini
Journal:  J Am Coll Cardiol       Date:  2002-06-05       Impact factor: 24.094

6.  Design and rationale of the Clinical Outcomes Utilizing Revascularization and Aggressive DruG Evaluation (COURAGE) trial Veterans Affairs Cooperative Studies Program no. 424.

Authors:  William E Boden; Robert A O'rourke; Koon K Teo; Pamela M Hartigan; David J Maron; William Kostuk; Merril Knudtson; Marcin Dada; Paul Casperson; Crystal L Harris; John A Spertus; Leslee Shaw; Bernard R Chaitman; G B John Mancini; Daniel S Berman; William S Weintraub
Journal:  Am Heart J       Date:  2006-06       Impact factor: 4.749

7.  Optimal medical therapy with or without PCI for stable coronary disease.

Authors:  William E Boden; Robert A O'Rourke; Koon K Teo; Pamela M Hartigan; David J Maron; William J Kostuk; Merril Knudtson; Marcin Dada; Paul Casperson; Crystal L Harris; Bernard R Chaitman; Leslee Shaw; Gilbert Gosselin; Shah Nawaz; Lawrence M Title; Gerald Gau; Alvin S Blaustein; David C Booth; Eric R Bates; John A Spertus; Daniel S Berman; G B John Mancini; William S Weintraub
Journal:  N Engl J Med       Date:  2007-03-26       Impact factor: 91.245

8.  Five-year follow-up of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease.

Authors:  Whady Hueb; Neuza Helena Lopes; Bernard J Gersh; Paulo Soares; Luiz A C Machado; Fabio B Jatene; Sergio A Oliveira; Jose A F Ramires
Journal:  Circulation       Date:  2007-03-06       Impact factor: 29.690

9.  Long-term outcomes of patients with acute myocardial infarction presenting to hospitals without catheterization laboratory and randomized to immediate thrombolysis or interhospital transport for primary percutaneous coronary intervention. Five years' follow-up of the PRAGUE-2 Trial.

Authors:  Petr Widimsky; Dana Bilkova; Martin Penicka; Martin Novak; Miroslava Lanikova; Vladimir Porizka; Ladislav Groch; Michael Zelizko; Tomas Budesinsky; Michael Aschermann
Journal:  Eur Heart J       Date:  2007-02-13       Impact factor: 29.983

Review 10.  Optimal timing of coronary invasive strategy in non-ST-segment elevation acute coronary syndromes: a systematic review and meta-analysis.

Authors:  Eliano P Navarese; Paul A Gurbel; Felicita Andreotti; Udaya Tantry; Young-Hoon Jeong; Marek Kozinski; Thomas Engstrøm; Giuseppe Di Pasquale; Waclaw Kochman; Diego Ardissino; Elvin Kedhi; Gregg W Stone; Jacek Kubica
Journal:  Ann Intern Med       Date:  2013-02-19       Impact factor: 25.391
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.